Levetiracetam use in pregnancy

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1692-1695

  Longo, Brian ^a   Forinash, Alicia B ^a   Murphy, Julie A ^a  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

Anticonvulsants; Epilepsy; Levetiracetam; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; FOLIC ACID;

CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG SAFETY; DRUG USE; EPILEPSY; FEMALE; HUMAN; KIDNEY BLOOD FLOW; MEDLINE; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY; THERAPY; THIRD TRIMESTER PREGNANCY;

ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; EPILEPSY; FEMALE; FOLIC ACID; HUMANS; PIRACETAM; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN B COMPLEX;

EID: 70449488466     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M231     Document Type: Review

References (18)

1. Pennell PB. 2005 AES annual course: evidence used to treat women with epilepsy. Epilepsia 2006;47(suppl 1):46-53. DOI 10.1111/j.1528-1167.2006.00660.x
2. Brodtkorb E, Reimers A. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy (abstract). Seizure 2008;2:160-165 DOI 10.1016/j.seizure.2007.11.015
3. Radtke R. Pharmacokinetics of levetiracetam. Epilepsia 2001;42:24-27
4. Tomson T, Palm R, Källén K, et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007;48:1111-1116 DOI 10.1111/j.1528-1167.2007.01032x
5. Pennell P, Koganti A, Helmers S, et al. The impact of pregnancy and childbirth on the elimination of levetiracetam (abstract). Epilepsia 2005;46(suppl 8):89.
6. Westin A, Reimers A, Helde G, Nakken K, Brodtkorb E. Serum concentration/ dose ratio of levetiracetam before, during and after pregnancy. Seizure 2008;17:192-198 DOI 10.1016/j.seizure.2007.11.027
7. Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006;67:1876-1879 (Pubitemid 44900776)
8. French J, Edrich P, Cramer J. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001;42:77-90. (Pubitemid 32973650)
9. Ten Berg K, Samren E, van Oppen A, Engelsman M, Lindhout D. Levetiracetam use and pregnancy outcome. Reprod Toxicol 2005;20:175-178 DOI 10.1016/j.reprotox.2004.12.001
10. Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 2003;4:447-448 DOI 10.1016/S1525-5050(03)00122-7
11. Long L, Helfant H. A case series of clinical and developmental outcomes in the offspring of pregnant women taking levetiracetam monotherapy (abstract). Epilepsia 2006;47:258.
12. Folic acid for the prevention of neural tube defects. American Academy of Pediatrics. Committee on Genetics. Pediatrics. 1999;104(2 pt 1):325-327
13. American College of Obstetrics and Gynecology (ACOG). ACOG Practice Bulletin 44: neural tube defects. Washington, DC: American College of Obstetrics and Gynecology, 2003.
14. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 2003;44(suppl 4):11-20.
15. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:944-948 (Pubitemid 28473381)
16. Tatum WO. Use of antiepileptic drugs in pregnancy. Expert Rev Neurotherapeutics 2006;6:1077-1086
17. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33:328-343 (Pubitemid 27480937)
18. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198 DOI 10.1136/jnnp.2005.074203